Search

Your search keyword '"Chamoun, Mira"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Chamoun, Mira" Remove constraint Author: "Chamoun, Mira" Journal alzheimer's & dementia Remove constraint Journal: alzheimer's & dementia
107 results on '"Chamoun, Mira"'

Search Results

1. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

2. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

3. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

4. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies

5. Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer’s disease

6. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

7. Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators

8. Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators

9. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

10. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

11. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies

12. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden

13. Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology

14. Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles

15. Verbal recognition declines in later Braak Stages compared to verbal delayed recall

16. Comparison of plasma amyloid, tau, and astrocyte biomarkers to identify AD pathophysiology

17. pTau heterogeneity as a measure for disease severity in incipient Alzheimer's disease

18. TRIAD multi‐dimensional biobank for biomarker discovery

19. Association between tau uptake and verbal fluency converge in language centers

20. Association between tau uptake and verbal fluency converge in language centers

21. Amyloid and tau pathologies associate with distinct aspects of the inflammatory cascade

22. Impact of meningeal and age‐related off‐target binding on longitudinal [18F]MK6240 quantification

23. Comparison of plasma amyloid, tau, and astrocyte biomarkers to identify AD pathophysiology

24. Impact of meningeal and age‐related off‐target binding on longitudinal [ 18 F]MK6240 quantification.

25. TRIAD multi‐dimensional biobank for biomarker discovery

26. Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles

27. Situating tau pathology and neuroinflammation along the principal gradients of brain organisation in Alzheimer’s disease

28. Longitudinal changes in plasma p‐tau181 as a surrogate variable to populational interventions

29. Apolipoprotein E ε4 associates with microglial activation in early Braak regions independently of amyloid‐β and tau

30. Associations between neutrophils and amyloid deposition in the Alzheimer’s disease spectrum

31. Discrepancy between plasma pTau181 and tau‐PET statuses

32. Plasma p‐Tau181 and p‐Tau231 offer complementary information to identify Alzheimer's disease pathophysiology

33. Adapting to the COVID‐19 pandemic in cohort studies: Validation of online assessments of cognition and neuropsychiatric symptoms in an aging population

34. Effect of temporal meta‐ROI and Braak1&2 ROI on the dissociation between plasma pTau181 and PET statuses

35. Verbal fluency associated with tau accumulation and not amyloid deposition in the Alzheimer’s disease spectrum

36. Cognitive health mediates the effect of hippocampal volume on COVID‐19‒related knowledge or anxiety change during the COVID‐19 pandemic

37. Microglial activation and tau propagate jointly across Braak stages

38. COVID‐19 pandemic: Quantifying the effects of the first lockdown on behavioral and cognitive measures using TASIC

40. Tau‐load in the lingual gyrus impacts anxiety levels during the COVID‐19 pandemic in participants of longitudinal observational studies in aging

41. Cognitive reserve: Evaluating the relationship between WASI‐II Matrix Reasoning and tau accumulation using [18F]MK6240 in monolingual and bilingual individuals

42. Tau‐PET is associated with knowledge of COVID‐19, COVID‐19‐related distress, and change in sleep quality during the pandemic

44. Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer's disease

45. Cerebrospinal fluid tau biomarkers in the prediction and concordance of neurofibrillary tangle and amyloid pathology

46. Interaction between amyloid and neuroinflammation on apathy along the Alzheimer’s disease spectrum

47. [ 18 F]MK‐6240 depicts early and late Braak stages of neurofibrillary tangles in preclinical and symptomatic subjects

49. Association between left hemisphere MK6240 uptake and language dysfunction in aging and Alzheimer’s disease

50. Synergistic underpinning of global amyloid and cingulate neuroinflammation underlies tau propagation in Alzheimer’s disease

Catalog

Books, media, physical & digital resources